A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes

By Chu Quincy   Forouzesh Bahram   Syed Samira   Mita Monica   Schwartz Garry   Cooper Joshua   Curtright Janet   Rowinsky Eric  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 357-357

Springer Publishing Company

Access to resources Recommend Favorite

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas

By Chu Quincy   Forouzesh Bahram   Syed Samira   Mita Monica   Schwartz Garry   Copper Joshua   Curtright Janet   Rowinsky Eric  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 359-367

Springer Publishing Company

Access to resources Recommend Favorite

Recent non-hydroxamate matrix metalloproteinase inhibitors

By Breuer Eli   Frant Julia   Reich Reuven  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 253-269

Informa Healthcare

Access to resources Recommend Favorite

Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis

By Su W   Gao F   Lu J   Wu W   Zhou G   Lu S  

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 986-994

Field House Publishing

Access to resources Recommend Favorite

Clinical Utility of Serum Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Concentrations in the Assessment of Liver Fibrosis due to Chronic Hepatitis B

By Liang B   Li Y   Zhao A   Xie F   Guo Z  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 631-639

Field House Publishing

Access to resources Recommend Favorite